InspireMD, Inc. announced on November 25, 2024, the appointment of Scott R. Ward to its Board of Directors. Mr. Ward brings extensive operational experience and a track record in the cardiovascular space, having previously served as CEO and President of Cardiovascular Systems, Inc. prior to its acquisition by Abbott.
The company's Chairman, Paul Stuka, stated that Mr. Ward's insights will be invaluable as InspireMD approaches the potential U.S. approval of CGuard Prime, which is considered the most significant value inflection point in its history. His experience is expected to have an immediate impact.
Mr. Ward's background includes nearly 30 years at Medtronic, Inc., where he held various leadership roles, including Senior Vice President and President of the CardioVascular, Neurological, and Diabetes businesses. His appointment is aimed at guiding the company through its next stages of advancing its carotid platform and pipeline innovation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.